Results 161 to 170 of about 519,396 (228)

Implementation of a digital system for the reporting of adverse events in nursing

Zeidy Vargas-Bermúdez, J. Pérez, Helder Noguera Mena   +2 more
openalex   +2 more sources

A Real-World Pharmacovigilance Study of Fruquintinib Based on the FDA Adverse Event Reporting System (FAERS) Database. [PDF]

Cancer Med
Xu Y, Wang D, Xu Y.
europepmc   +1 more source

Adverse event analysis and signal detection of calcitonin gene-related peptide inhibitors using the FDA Adverse Event Reporting System database [PDF]

Nai Lee, Jihoon Ok, Jong‐Hyun Lee, Su‐jin Rhee, Yun Kim   +4 more
openalex   +1 more source

Safety comparisons among different subcutaneous anticoagulants for venous thromboembolism using FDA adverse event reporting system [PDF]

Bo‐Wen Lu, Jiacheng Li, Ming‐Tao Wen, Di Luo, Yuqi Guo, Gang Li   +5 more
openalex   +1 more source

Drug-induced dermatomyositis: a pharmacovigilance study of the FDA adverse event reporting system. [PDF]

Front Pharmacol
Bi J, Xie H, Yang Y, Chen Q, Cui B, Xiao Z.   +5 more
europepmc   +1 more source

Safety Surveillance for Hepatitis A Vaccine using the U.S. Vaccine Adverse Event Reporting System (VAERS) database. [PDF]

Hum Vaccin Immunother
Ren L, Wang J, Jiang R, Han Y, Li X, Zhang W, Guo S, Shu L.   +7 more
europepmc   +1 more source

Drug-Induced Intestinal Angioedema: A Disproportionality Analysis Using the United States Food and Drug Administration Adverse Event Reporting System Database and Literature Review

Poovizhi Bharathi Rajaduraivelpandian, Rashmi Rao, Ashwin Kamath   +2 more
openalex   +1 more source

Safety of penicillamine and trientine in the treatment of Wilson's disease: An analysis of the FDA Adverse Event Reporting System (FAERS) database. [PDF]

PLoS One
Qian W, Xu K, Li S, Zhang Z, Hou X, Min B, Ling J, Zhu X, Zhou H, Xu W, Yang W, Cao S, Chen Y.   +12 more
europepmc   +1 more source

Exploring Connections Between Weight‐Loss Medications and Thyroid Cancer: A Look at the FDA Adverse Event Reporting System Database [PDF]

Christophe Abi Zeid Daou, Omar Aboul Hosn, Lana Ghzayel, Marc Mourad   +3 more
openalex   +1 more source

Signal mining and safety profile analysis of lapatinib: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database. [PDF]

J Pharm Policy Pract
Cerbito E, Diab MI, Alhoshani A, Maayah ZH.   +3 more
europepmc   +1 more source